These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 23625795)
41. Expression of the Epithelial Cell Adhesion Molecule and Cytokeratin 8 in Head and Neck Squamous Cell Cancer: A Comparative Study. Andratschke M; Hagedorn H; Nerlich A Anticancer Res; 2015 Jul; 35(7):3953-60. PubMed ID: 26124342 [TBL] [Abstract][Full Text] [Related]
42. Estimation of groin recurrence risk in patients with squamous cell vulvar carcinoma by the assessment of marker gene expression in the lymph nodes. Kowalewska M; Radziszewski J; Goryca K; Bujko M; Oczko-Wojciechowska M; Jarzab M; Siedlecki JA; Bidzinski M BMC Cancer; 2012 Jun; 12():223. PubMed ID: 22673103 [TBL] [Abstract][Full Text] [Related]
43. Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma. León X; Bothe C; García J; Parreño M; Alcolea S; Quer M; Vila L; Camacho M Oncotarget; 2015 Nov; 6(35):37398-409. PubMed ID: 26460957 [TBL] [Abstract][Full Text] [Related]
44. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma. Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044 [TBL] [Abstract][Full Text] [Related]
45. Sentinel lymph node biopsy in head and neck squamous cell carcinoma. Pitman KT; Johnson JT; Brown ML; Myers EN Laryngoscope; 2002 Dec; 112(12):2101-13. PubMed ID: 12461328 [TBL] [Abstract][Full Text] [Related]
46. Molecular assay to detect metastatic head and neck squamous cell carcinoma. Becker MT; Shores CG; Yu KK; Yarbrough WG Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):21-7. PubMed ID: 14732763 [TBL] [Abstract][Full Text] [Related]
48. Limited suitability of EpCAM for molecular staging of tumor borders in head and neck cancer. Andratschke M; Hagedorn H; Luebbers CW; Schmitt B; Lang S; Zeidler R; Wollenberg B Anticancer Res; 2006; 26(1A):153-8. PubMed ID: 16475692 [TBL] [Abstract][Full Text] [Related]
49. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck. Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593 [TBL] [Abstract][Full Text] [Related]
50. Accuracy of Ultrasonography-Guided Fine-Needle Aspiration in Detecting Persistent Nodal Disease After Chemoradiotherapy. Fleischman GM; Thorp BD; Difurio M; Hackman TG JAMA Otolaryngol Head Neck Surg; 2016 Apr; 142(4):377-82. PubMed ID: 26967355 [TBL] [Abstract][Full Text] [Related]
51. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070 [TBL] [Abstract][Full Text] [Related]
52. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma. Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648 [TBL] [Abstract][Full Text] [Related]
53. The expression of activin receptor-like kinase 1 among patients with head and neck cancer. Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486 [TBL] [Abstract][Full Text] [Related]
54. Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles. Tveito S; Andersen K; Kåresen R; Fodstad Ø Breast Cancer Res; 2011 Aug; 13(4):R75. PubMed ID: 21816090 [TBL] [Abstract][Full Text] [Related]
55. A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence. Zamunér FT; Karia BT; de Oliveira CZ; Santos CR; Carvalho AL; Vettore AL Mol Cancer Ther; 2015 Mar; 14(3):828-34. PubMed ID: 25564441 [TBL] [Abstract][Full Text] [Related]
56. Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer. Takes RP; Baatenburg de Jong RJ; Wijffels K; Schuuring E; Litvinov SV; Hermans J; van Krieken JH J Pathol; 2001 Jul; 194(3):298-302. PubMed ID: 11439361 [TBL] [Abstract][Full Text] [Related]
57. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck. Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044 [TBL] [Abstract][Full Text] [Related]
58. Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes. Capaccio P; Pruneri G; Carboni N; Pagliari AV; Quatela M; Cesana BM; Pignataro L Head Neck; 2000 May; 22(3):234-40. PubMed ID: 10748446 [TBL] [Abstract][Full Text] [Related]
59. Histological assessment of cervical lymph node identifies patients with head and neck squamous cell carcinoma (HNSCC): who would benefit from chemoradiation after surgery? Wan XC; Egloff AM; Johnson J Laryngoscope; 2012 Dec; 122(12):2712-22. PubMed ID: 23060119 [TBL] [Abstract][Full Text] [Related]
60. Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma. Kikuchi K; Noguchi A; Kasajima R; Miyagi Y; Hoshino D; Koshikawa N; Kubota A; Yokose T; Takano Y Tumour Biol; 2015 Sep; 36(10):7865-72. PubMed ID: 25946975 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]